相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation
Katarzyna Mizia-Stec et al.
CYTOKINE (2018)
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells
Rosalba Florio et al.
SCIENTIFIC REPORTS (2018)
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
Liu-Ya Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis
Hadi Khalil et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
Edward R. Smith et al.
SCIENTIFIC REPORTS (2017)
EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling
Sheng-an Su et al.
CIRCULATION RESEARCH (2017)
Atrial Fibrillation Epidemiology, Pathophysiology, and Clinical Outcomes
Laila Staerk et al.
CIRCULATION RESEARCH (2017)
JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate
Yu Chen et al.
CARDIOVASCULAR RESEARCH (2017)
Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications
Dennis H. Lau et al.
EUROPEAN HEART JOURNAL (2016)
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
Huixin Hao et al.
ONCOTARGET (2016)
Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes
Shih-Yu Huang et al.
ONCOTARGET (2016)
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
Rupal Mehta et al.
JAMA CARDIOLOGY (2016)
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice
Anna Biernacka et al.
CIRCULATION-HEART FAILURE (2015)
Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications
Mikhail S. Dzeshka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Fibroblast Growth Factor-23 and Incident Atrial Fibrillation The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)
Jehu S. Mathew et al.
CIRCULATION (2014)
Atrial Fibrillation: An Observational Study with Outpatients
Gaston Albina et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2014)
The epidemiology of atrial fibrillation in end-stage renal disease
Panagiotis Korantzopoulos et al.
JOURNAL OF NEPHROLOGY (2013)
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
Robert J. J. O'Donoghue et al.
EMBO MOLECULAR MEDICINE (2012)
The Origin of Fibroblasts and Mechanism of Cardiac Fibrosis
Guido Krenning et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure-with advanced age
JJ Jacoby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
